Preclinical safety study of a gemcitabine-controlled release polymer for locoregional administration in pancreatic cancer
Author:
Funder
Federación Española de Enfermedades Raras
Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
Agencia Estatal de Investigación
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference55 articles.
1. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system;Sánchez-García;Surgery,2014
2. Usefulness of thermographic analysis to control temperature homogeneity in the development and implementation of a closed recirculating CO 2 chemohyperthermia model;Padilla-Valverde;Int. J. Hyperther.,2017
3. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4+
4. Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41;Padilla-Valverde;J. Gastrointest. Oncol.,2021
5. Gemcitabine. New first-line therapy for pancreatic cancer;King;Cancer Pract.,1996
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3